Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome.

Wang L, Rosé CD, Foley KP, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Fernández-Martín J, Guly C, Hachulla E, Harjacek M, Mackensen F, Merino R, Modesto C, Naranjo Hernández A, Pajot C, Ramanan AV, Thatayatikom A, Thomée C, Vastert S, Votta BJ, Bertin J, Wouters CH.

Rheumatology (Oxford). 2018 Apr 7. doi: 10.1093/rheumatology/key090. [Epub ahead of print]

PMID:
29635517
2.

Randomized Controlled Study to Evaluate the Efficacy of Adalimumab in Patients with Different Forms of Refractory Uveitis.

Mackensen F, Heinz C, Jakob E, Grewing V, Lorenz HM, Heiligenhaus A, Max R, Becker MD.

Ocul Immunol Inflamm. 2018;26(7):1015-1022. doi: 10.1080/09273948.2017.1411518. Epub 2017 Dec 29.

PMID:
29286865
3.

Enteric-coated mycophenolate sodium in the treatment of non-infectious intermediate uveitis: results of a prospective, controlled, randomised, open-label, early terminated multicentre trial.

Deuter CME, Engelmann K, Heiligenhaus A, Lanzl I, Mackensen F, Ness T, Pleyer U, Stuebiger N, Wilhelm B, Luedtke H, Zierhut M, Doycheva D; MYCUV-IIT02 Study Group.

Br J Ophthalmol. 2018 May;102(5):647-653. doi: 10.1136/bjophthalmol-2017-310156. Epub 2017 Sep 13.

PMID:
28903965
4.

Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.

Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, Guly CM, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Modesto C, Naranjo A, Oliveira-Knupp S, Özen S, Pajot C, Ramanan AV, Russo R, Susic G, Thatayatikom A, Thomée C, Vastert S, Bertin J, Arostegui JI, Rose CD, Wouters CH.

Am J Ophthalmol. 2018 Mar;187:158-166. doi: 10.1016/j.ajo.2017.08.017. Epub 2017 Sep 6.

PMID:
28887115
5.

In Vivo Laser Confocal Microscopy Using the HRT-Rostock Cornea Module: Diversity and Diagnostic Implications in Patients with Uveitis.

Lim LL, Xie J, Chua CC, Wong T, Hoang LT, Becker MD, Suhler EB, Rosenbaum JT, Mackensen F.

Ocul Immunol Inflamm. 2018;26(6):900-909. doi: 10.1080/09273948.2017.1298818. Epub 2017 May 31.

PMID:
28562149
6.

Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.

Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.

J Rheumatol. 2016 Dec;43(12):2183-2188. Epub 2016 Sep 15.

PMID:
27633821
7.

Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis.

Laible M, Jarius S, Mackensen F, Schmidt-Bacher A, Platten M, Haas J, Albrecht P, Wildemann B.

PLoS One. 2016 May 12;11(5):e0155322. doi: 10.1371/journal.pone.0155322. eCollection 2016.

8.

In vivo confocal microscopy of inflammatory cells in the corneal subbasal nerve plexus in patients with different subtypes of anterior uveitis.

Postole AS, Knoll AB, Auffarth GU, Mackensen F.

Br J Ophthalmol. 2016 Nov;100(11):1551-1556. doi: 10.1136/bjophthalmol-2015-307429. Epub 2016 Jan 28.

9.

Acute Retinal Necrosis: Diagnostic and Treatment Strategies in Germany.

Winterhalter S, Stuebiger N, Maier AK, Pleyer U, Heiligenhaus A, Mackensen F, Zierhut M, Joussen AM, Ness T.

Ocul Immunol Inflamm. 2016 Oct;24(5):537-43. doi: 10.3109/09273948.2015.1034375. Epub 2015 Sep 23.

PMID:
26399848
10.

Ocular toxoplasmosis: background and evidence for an antibiotic prophylaxis.

Reich M, Mackensen F.

Curr Opin Ophthalmol. 2015 Nov;26(6):498-505. doi: 10.1097/ICU.0000000000000205. Review.

PMID:
26367087
11.

Influence of drug therapy on the risk of recurrence of ocular toxoplasmosis.

Reich M, Becker MD, Mackensen F.

Br J Ophthalmol. 2016 Feb;100(2):195-9. doi: 10.1136/bjophthalmol-2015-306650. Epub 2015 Jul 10.

PMID:
26163541
12.

Further specification required. In reply.

Mackensen F, Ness T.

Dtsch Arztebl Int. 2015 Mar 13;112(11):194. doi: 10.3238/arztebl.2015.0194b. No abstract available.

13.

Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis.

Tappeiner C, Miserocchi E, Bodaghi B, Kotaniemi K, Mackensen F, Gerloni V, Quartier P, Lutz T, Heiligenhaus A.

J Rheumatol. 2015 Apr;42(4):706-11. doi: 10.3899/jrheum.140410. Epub 2015 Feb 1.

PMID:
25641892
14.

[Guideline of the Professional Association of German Ophthalmologists eV and the German Ophthalmology Society:. Guideline No. 24a:. Uveitis intermedia (July 2014)].

Mackensen F, Baydoun L, Garweg J, Hudde T, Heiligenhaus A; Professional Association of German Ophthalmologists; German Ophthalmology Society.

Klin Monbl Augenheilkd. 2015 Jan;232(1):79-84. doi: 10.1055/s-0034-1383197. Epub 2015 Jan 22. German. No abstract available.

PMID:
25611501
15.

Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.

Rosé CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Cimaz R, Espada G, Fernandez-Martin J, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Naranjo A, Oliveira-Knupp S, Pajot C, Russo R, Thomée C, Vastert S, Wulffraat N, Arostegui JI, Foley KP, Bertin J, Wouters CH.

Rheumatology (Oxford). 2015 Jun;54(6):1008-16. doi: 10.1093/rheumatology/keu437. Epub 2014 Nov 20.

PMID:
25416713
16.

[Intermediate uveitis: guidelines of the German Ophthalmological Society and the Professional Association of German Ophthalmologists].

Mackensen F, Baydoun L, Garweg J, Heiligenhaus A, Hudde T; German Ophthalmological Society; Association of German Ophthalmologists.

Ophthalmologe. 2014 Nov;111(11):1033-40. doi: 10.1007/s00347-014-3198-6. German. No abstract available.

PMID:
25412601
17.

Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.

Riemens A, Bromberg J, Touitou V, Sobolewska B, Missotten T, Baarsma S, Hoyng C, Cordero-Coma M, Tomkins-Netzer O, Rozalski A, Tugal-Tutkun I, Guex-Crosier Y, Los LI, Bollemeijer JG, Nolan A, Pawade J, Willermain F, Bodaghi B, ten Dam-van Loon N, Dick A, Zierhut M, Lightman S, Mackensen F, Moulin A, Erckens R, Wensing B, le Hoang P, Lokhorst H, Rothova A.

JAMA Ophthalmol. 2015 Feb;133(2):191-7. doi: 10.1001/jamaophthalmol.2014.4755.

18.

Time patterns of recurrences and factors predisposing for a higher risk of recurrence of ocular toxoplasmosis.

Reich M, Ruppenstein M, Becker MD, Mackensen F.

Retina. 2015 Apr;35(4):809-19. doi: 10.1097/IAE.0000000000000361.

PMID:
25299969
19.

Ocular changes during pregnancy.

Mackensen F, Paulus WE, Max R, Ness T.

Dtsch Arztebl Int. 2014 Aug 18;111(33-34):567-75; quiz 576. doi: 10.3238/arztebl.2014.0567. Review.

20.

Characterisation of uveitis in association with multiple sclerosis.

Messenger W, Hildebrandt L, Mackensen F, Suhler E, Becker M, Rosenbaum JT.

Br J Ophthalmol. 2015 Feb;99(2):205-9. doi: 10.1136/bjophthalmol-2014-305518. Epub 2014 Aug 28.

PMID:
25170065
21.

[Uveitis in multiple sclerosis : Overview and perspectives].

Hildebrandt AL, Mackensen F.

Ophthalmologe. 2014 Aug;111(8):733-9. doi: 10.1007/s00347-013-2984-x. Review. German.

PMID:
25092024
22.

Risk of Recurrence of Preexisting Ocular Toxoplasmosis during Pregnancy.

Reich M, Ruppenstein M, Becker MD, Mackensen F.

Ocul Immunol Inflamm. 2015 Jun;23(3):240-5. doi: 10.3109/09273948.2014.916306. Epub 2014 May 19.

PMID:
24841072
23.

[Posterior uveitis. Part 1: diagnostics and basic concepts of therapy].

Heiligenhaus A, Breitbach M, Spital G, Stübiger N, Winterhalter S, Deuter C, Becker M, Mackensen F.

Klin Monbl Augenheilkd. 2014 Apr;231(4):457-69; quiz 470-1. doi: 10.1055/s-0033-1357916. Epub 2014 Apr 25. German. No abstract available.

PMID:
24771192
24.

[Posterior uveitis. Part 2: specific disorders].

Heiligenhaus A, Breitbach M, Spital G, Stübiger N, Winterhalter S, Deuter C, Becker M, Mackensen F.

Klin Monbl Augenheilkd. 2014 May;231(5):555-79. doi: 10.1055/s-0033-1357918. Epub 2014 Apr 24. German. No abstract available.

PMID:
24764170
25.

Three years of experience with QuantiFERON-TB gold testing in patients with uveitis.

Jakob E, Max R, Zimmermann S, Dalpke AH, Alle W, Becker M, Mackensen F.

Ocul Immunol Inflamm. 2014 Dec;22(6):478-84. doi: 10.3109/09273948.2013.866255. Epub 2014 Jan 10.

PMID:
24410312
26.

Frequency of dendritiform inflammatory cells in the cornea in herpetic anterior uveitis without clinical keratitis and Fuchs uveitis.

Knoll AB, Postole AS, Auffarth GU, Mackensen F.

J Ophthalmic Inflamm Infect. 2014 Dec 31;4:31. doi: 10.1186/s12348-014-0031-y. eCollection 2014.

27.

Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement.

Pelegrin L, Jakob E, Schmidt-Bacher A, Schwenger V, Becker M, Max R, Lorenz HM, Mackensen F.

J Rheumatol. 2014 Jan;41(1):84-90. doi: 10.3899/jrheum.130206. Epub 2013 Nov 15.

PMID:
24241484
28.

Use of intravitreal rituximab for treatment of vitreoretinal lymphoma.

Larkin KL, Saboo US, Comer GM, Forooghian F, Mackensen F, Merrill P, Sen HN, Singh A, Essex RW, Lake S, Lim LL, Vasconcelos-Santos DV, Foster CS, Wilson DJ, Smith JR.

Br J Ophthalmol. 2014 Jan;98(1):99-103. doi: 10.1136/bjophthalmol-2013-304043. Epub 2013 Oct 24.

PMID:
24158837
29.

Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial.

Mackensen F, Jakob E, Springer C, Dobner BC, Wiehler U, Weimer P, Rohrschneider K, Fiehn C, Max R, Storch-Hagenlocher B, Becker MD.

Am J Ophthalmol. 2013 Sep;156(3):478-486.e1. doi: 10.1016/j.ajo.2013.05.002. Epub 2013 Jun 17.

PMID:
23786783
30.

Spontaneous dissociation and dislocation of Retisert pellet.

Akduman L, Cetin EN, Levy J, Becker MD, Mackensen F, Lim LL.

Ocul Immunol Inflamm. 2013;21(1):87-9. doi: 10.3109/09273948.2012.736585.

PMID:
23590151
31.

[Seclusio pupillae, cataracta complicata in chronic, recurrent panuveitis: combined surgery with synechiolyses, pupilloplastic, cataract surgery and intravitreal dexamethasone implants].

Kretz FT, Mackensen F, Auffarth GU.

Klin Monbl Augenheilkd. 2013 Feb;230(2):168-9. doi: 10.1055/s-0032-1328162. Epub 2013 Feb 21. German. No abstract available.

PMID:
23430680
32.

Visual functions in phenylketonuria-evaluating the dopamine and long-chain polyunsaturated fatty acids depletion hypotheses.

Gramer G, Förl B, Springer C, Weimer P, Haege G, Mackensen F, Müller E, Völcker HE, Hoffmann GF, Lindner M, Krastel H, Burgard P.

Mol Genet Metab. 2013 Jan;108(1):1-7. doi: 10.1016/j.ymgme.2012.10.021. Epub 2012 Oct 30.

PMID:
23219290
33.

A three-centre experience with adalimumab for the treatment of non-infectious uveitis.

Dobner BC, Max R, Becker MD, Heinz C, Veltrup I, Heiligenhaus A, Barisani-Asenbauer T, Mackensen F.

Br J Ophthalmol. 2013 Feb;97(2):134-8. doi: 10.1136/bjophthalmol-2011-301401. Epub 2012 Dec 4.

PMID:
23212204
34.

Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization.

Mansour AM, Mackensen F, Mahendradas P, Khairallah M, Lai TY, Bashshur Z.

Clin Ophthalmol. 2012;6:1233-7. doi: 10.2147/OPTH.S34294. Epub 2012 Aug 1.

35.

Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization.

Mansour AM, Arevalo JF, Fardeau C, Hrisomalos EN, Chan WM, Lai TY, Ziemssen F, Ness T, Sibai AM, Mackensen F, Wolf A, Hrisomalos N, Heiligenhaus A, Spital G, Jo Y, Gomi F, Ikuno Y, Akesbi J, LeHoang P, Adan A, Mahendradas P, Khairallah M, Guthoff R, Ghandour B, Küçükerdönmez C, Kurup SK.

Can J Ophthalmol. 2012 Jun;47(3):269-74. doi: 10.1016/j.jcjo.2012.03.042.

PMID:
22687305
36.

Ocular outcome and frequency of neurological manifestations in patients with acute posterior multifocal placoid pigment epitheliopathy (APMPPE).

Thomas BC, Jacobi C, Korporal M, Becker MD, Wildemann B, Mackensen F.

J Ophthalmic Inflamm Infect. 2012 Sep;2(3):125-31. doi: 10.1007/s12348-012-0077-7. Epub 2012 May 11.

37.

[Management of patients with ocular diseases during pregnancy. Diabetes, glaucoma and uveitis].

Mackensen F, Max R.

Ophthalmologe. 2012 Mar;109(3):235-41. doi: 10.1007/s00347-011-2461-3. Review. German.

PMID:
22447420
38.

[Ophthalmological treatment during pregnancy. Healthy balance between treatment and safety].

Mackensen F.

Ophthalmologe. 2012 Mar;109(3):219-20. doi: 10.1007/s00347-011-2458-y. German. No abstract available.

PMID:
22447417
39.

Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.

Heiligenhaus A, Foeldvari I, Edelsten C, Smith JR, Saurenmann RK, Bodaghi B, de Boer J, Graham E, Anton J, Kotaniemi K, Mackensen F, Minden K, Nielsen S, Rabinovich EC, Ramanan AV, Strand V; Multinational Interdisciplinary Working Group for Uveitis in Childhood.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1365-72. doi: 10.1002/acr.21674. Review.

40.

A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene.

Fritsche LG, Fleckenstein M, Fiebig BS, Schmitz-Valckenberg S, Bindewald-Wittich A, Keilhauer CN, Renner AB, Mackensen F, Mößner A, Pauleikhoff D, Adrion C, Mansmann U, Scholl HP, Holz FG, Weber BH.

Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2112-8. doi: 10.1167/iovs.11-8785.

PMID:
22427542
41.

Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

Heiligenhaus A, Michels H, Schumacher C, Kopp I, Neudorf U, Niehues T, Baus H, Becker M, Bertram B, Dannecker G, Deuter C, Foeldvari I, Frosch M, Ganser G, Gaubitz M, Gerdes G, Horneff G, Illhardt A, Mackensen F, Minden K, Pleyer U, Schneider M, Wagner N, Zierhut M; German Ophthalmological Society; Society for Childhood and Adolescent Rheumatology; German Society for Rheumatology.

Rheumatol Int. 2012 May;32(5):1121-33. doi: 10.1007/s00296-011-2126-1. Epub 2011 Nov 15. Review.

PMID:
22083610
42.

Difficulties of interpreting Borrelia serology in patients with uveitis.

Mackensen F, Zimmermann S, Alle W, Max R, Jakob E, Becker MD, Thiemeyer D.

Ocul Immunol Inflamm. 2011 Aug;19(4):227-31. doi: 10.3109/09273948.2011.568662.

PMID:
21770797
43.

Progression of age-related geographic atrophy: role of the fellow eye.

Fleckenstein M, Schmitz-Valckenberg S, Adrion C, Visvalingam S, Göbel AP, Mössner A, von Strachwitz CN, Mackensen F, Pauleikhoff D, Wolf S, Mansmann U, Holz FG; FAM Study Group.

Invest Ophthalmol Vis Sci. 2011 Aug 22;52(9):6552-7. doi: 10.1167/iovs.11-7298.

PMID:
21757586
44.

[Therapy for childhood uveitis: biologics: too often--too late?].

Mackensen F, Lutz T.

Ophthalmologe. 2011 Mar;108(3):213-21. doi: 10.1007/s00347-010-2260-2. Review. German.

PMID:
21350869
45.

[Anti-TNF-α treatment for uveitis. Analysis of the current situation].

Pleyer U, Mackensen F, Winterhalter S, Stübiger N.

Ophthalmologe. 2011 Jan;108(1):13-20. doi: 10.1007/s00347-010-2256-y. Review. German.

PMID:
21181169
46.

HLA-DRB1*0102 is associated with TINU syndrome and bilateral, sudden-onset anterior uveitis but not with interstitial nephritis alone.

Mackensen F, David F, Schwenger V, Smith LK, Rajalingam R, Levinson RD, Austin CR, Houghton D, Martin TM, Rosenbaum JT.

Br J Ophthalmol. 2011 Jul;95(7):971-5. doi: 10.1136/bjo.2010.187955. Epub 2010 Nov 7.

PMID:
21059595
47.

Clinical manifestations and longterm followup of a patient with CINCA/NOMID syndrome.

Ebrahimi-Fakhari D, Wahlster L, Mackensen F, Blank N.

J Rheumatol. 2010 Oct;37(10):2196-7. doi: 10.3899/jrheum.100290. No abstract available.

PMID:
20889617
48.

[Ocular involvement in spondyloarthropathies: HLA B27 associated uveitis].

Max R, Lorenz HM, Mackensen F.

Z Rheumatol. 2010 Jul;69(5):397-402. doi: 10.1007/s00393-009-0576-6. Review. German.

PMID:
20544353
49.

Tuberculous uveitis.

Mackensen F, Becker M, Zimmermann S.

Ophthalmology. 2010 Feb;117(2):401-2; author reply 402. doi: 10.1016/j.ophtha.2009.09.017. No abstract available.

PMID:
20141860
50.

Interferons and their potential in the treatment of ocular inflammation.

Mackensen F, Max R, Becker MD.

Clin Ophthalmol. 2009;3:559-66. Epub 2009 Oct 19.

Supplemental Content

Loading ...
Support Center